We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse events as its current valuation is extremely ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Eli Lilly (LLY) closed the latest trading day ... changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks ...

It's hard to argue with the kinds of results Eli Lilly ( LLY 1.71%) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly (LLY) closed the most recent trading day at $912.76, moving -1.82% from the previous trading session.

LLY's R&D expenses ratio of 24.4% underscores its highly promising R&D efforts, explaining their robust top/ bottom-line performance and promising FY2025 guidance. With the stock now trading ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.